company
Isomorphic Labs is an Alphabet-owned, DeepMind-spun-out company using AI models to design new drugs and accelerate pharmaceutical discovery.
The $20mn round buys roughly 0.53 per cent of the company, and no product exists yet. Read the number as a reference price for pre-revenue bio-AI, not a verdict on the science.
Reality
Business Insider, citing eight current and former employees, reports that Google's cofounder holds no executive title while making technical calls on Gemini from a desk the new DeepMind SVP shares. Google declined to comment.
Reality
Academics get all 9 billion single-base predictions through a browser at no cost, while commercial users wait on a Google Cloud licence whose terms DeepMind has not published, including for its own sister company.
Reality
The work is careful basic genetics: cloned sequences, predicted protein folds, and one gene switched off at a time. Whether it touches India's 56% edible oil import share depends on breeding that has not happened yet.
Reality
Only people can be inventors under US law, so the file on an AI-derived molecule has to show human contribution. Teams that do not document it are building patents someone can challenge.
Reality
The startup opened a robotic "human data center" near San Francisco on the thesis that AI drug discovery is limited by causal human experiments, not model capacity.
Reality
The startup opened what it calls the world's largest human data center last week. Its diagnosis of the field is testable; most of the evidence for its own machines is self-reported.
Reality
Management says scale is starting to show up as operating leverage. The release as supplied gives a backlog, power figures and more than $14bn of fresh capital, but no margin numbers.
Reality